Bristol-Myers Squibb (BMY) Earnings Date
The next earnings date for Bristol-Myers Squibb (BMY) is expected by Feb 3, 2027, per the data provider's calendar.
- Next earnings date
- Feb 3, 2027
- expected by · quarter ending Dec '26
- Consensus EPS
- $1.50
- Dec '26 quarter · 15 analysts
- Consensus revenue
- $12.7B
- Dec '26 quarter · 13 analysts
- Latest stored quarter
- EPS 1.05
- revenue $13.1B · reported Oct 29, 2026
Does this company deliver against its own promises? Earnings are a check on the thesis, not a catalyst to chase.
1 of 2 scored quarters beat.
| Report | Est EPS | Act EPS | Surprise | Est rev | Act rev | Rev surp. | Reaction |
|---|---|---|---|---|---|---|---|
| Oct 29, 20268-K, before open · 6:59 am ET | 1.10 | 1.05 | −4.8% | $12.7B | $13.1B | +2.7% | +1.4%release day |
| Jul 30, 20268-K, before open · 7:05 am ET | 1.60 | 1.62 | +1.5% | $11.7B | $13.0B | +10.5% | +2.8%release day |
| Apr 30, 20268-K, before open · 7:01 am ET | — | 1.31 | — | — | $11.5B | — | +5.2%release day |
| Feb 5, 20268-K, before open · 7:07 am ET | — | 0.54 | — | — | $12.5B | — | +3.3%release day |
| Oct 30, 20258-K, before open · 7:09 am ET | — | 1.08 | — | — | $12.2B | — | +7.1%release day |
| Jul 31, 20258-K, before open · 7:06 am ET | — | 0.64 | — | — | $12.3B | — | −5.8%release day |
| Apr 24, 20258-K, before open · 7:11 am ET | — | 1.20 | — | — | $11.2B | — | +0.3%release day |
| Feb 6, 20258-K, before open · 7:46 am ET | — | 0.05 | — | — | $12.3B | — | −3.8%release day |
Estimate-vs-actual scoring began Jul 2026 and is still accruing: 2 of the 8 quarters above carry a scored estimate. We never backfill an estimate we didn't observe.
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 15 | 7 | 16 | 17 |
| Avg estimate | 1.50 | 1.52 | 6.44 | 6.70 |
| Low estimate | 1.44 | 1.38 | 6.18 | 6.13 |
| High estimate | 1.60 | 1.65 | 6.57 | 7.25 |
| Year-ago EPS | 0.54 | 1.31 | 3.46 | 6.44E |
| Implied growth | +177.7% | +16.2% | +86.2% | +4.0% |
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 13 | 5 | 19 | 20 |
| Avg estimate | $12.7B | $11.3B | $50.2B | $48.8B |
| Low estimate | $12.5B | $10.9B | $49.7B | $47.5B |
| High estimate | $13.0B | $11.6B | $50.6B | $50.8B |
| Year-ago revenue | $12.5B | $11.5B | $48.2B | $50.2BE |
| Implied growth | +1.3% | −1.4% | +4.1% | −2.7% |
| Snapshot age | Dec '26, period ending Dec 30, 2026 | Mar '27, period ending Mar 30, 2027 | FY26, period ending Dec 31, 2026 | FY27, period ending Dec 31, 2027 |
|---|---|---|---|---|
| Current estimate | 1.50 | 1.52 | 6.44 | 6.70 |
| 7 days ago | 1.52 | — | 6.44 | 6.66 |
| 30 days ago | 1.61 | — | 6.32 | 6.62 |
| 60 days ago | 1.59 | — | 6.93 | 6.55 |
| 90 days ago | 1.58 | — | 6.74 | 6.44 |
Estimate history accrues from our nightly snapshots. The 7/30/60/90-day rows fill in as tracking continues. Each column follows one fiscal period back through our snapshots; a dash means we had not recorded that period at that age. A rising bar makes a beat streak more meaningful; a falling one manufactures beats.
Dec '26 quarter consensus moved $1.58 → $1.50 over 90 tracked days, the same quarter at both ends. Per-analyst up/down revision counts aren't in our data feed. We show the bar's actual movement instead of guessing.
Common questions
When does Bristol-Myers Squibb report earnings next?
Bristol-Myers Squibb's next earnings date is expected by Feb 3, 2027, per the data provider's calendar.
What were Bristol-Myers Squibb's latest quarterly earnings?
Bristol-Myers Squibb reported diluted EPS of 1.05 and revenue of $13.1B on Oct 29, 2026.
How did Bristol-Myers Squibb's stock move after its last earnings report?
Bristol-Myers Squibb moved +1.4% in the session after its Oct 29, 2026 report.

